These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3506620)

  • 1. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial.
    Mayhew IG; Brown CM; Stowe HD; Trapp AL; Derksen FJ; Clement SF
    J Vet Intern Med; 1987; 1(1):45-50. PubMed ID: 3506620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of oxidative injury of the spinal cord in 2 horses with equine degenerative myeloencephalopathy.
    Wong DM; Ghosh A; Fales-Williams AJ; Haynes JS; Kanthasamy AG
    Vet Pathol; 2012 Nov; 49(6):1049-53. PubMed ID: 22390882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine degenerative myeloencephalopathy in Lusitano horses.
    Finno CJ; Higgins RJ; Aleman M; Ofri R; Hollingsworth SR; Bannasch DL; Reilly CM; Madigan JE
    J Vet Intern Med; 2011; 25(6):1439-46. PubMed ID: 22092640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.
    Finno CJ; Kaese HJ; Miller AD; Gianino G; Divers T; Valberg SJ
    Vet Ophthalmol; 2017 Jul; 20(4):304-309. PubMed ID: 27491953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine neuroaxonal dystrophy/degenerative myeloencephalopathy in Gypsy Vanner horses.
    Powers A; Peek SF; Reed S; Donnelly CG; Tinkler S; Gasper D; Woolard KD; Finno CJ
    J Vet Intern Med; 2024; 38(3):1792-1798. PubMed ID: 38613444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insights into equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy.
    Young AE; Finno CJ
    Vet J; 2024 Jun; 305():106129. PubMed ID: 38734404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and liver copper values in horses with equine degenerative myeloencephalopathy.
    Dill SG; Hintz HF; deLahunta A; Waldron CH
    Can J Vet Res; 1989 Jan; 53(1):29-32. PubMed ID: 2914224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization.
    Finno CJ; Valberg SJ; Shivers J; D'Almeida E; Armién AG
    Vet Pathol; 2016 Jan; 53(1):77-86. PubMed ID: 26253880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, viral, and genetic evaluation of equine degenerative myeloencephalopathy in a family of Appaloosas.
    Blythe LL; Hultgren BD; Craig AM; Appell LH; Lassen ED; Mattson DE; Duffield D
    J Am Vet Med Assoc; 1991 Mar; 198(6):1005-13. PubMed ID: 2032902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroaxonal dystrophy associated with vitamin E deficiency in two Haflinger horses.
    Baumgärtner W; Frese K; Elmadfa I
    J Comp Pathol; 1990 Jul; 103(1):114-9. PubMed ID: 2394844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine degenerative myeloencephalopathy.
    Miller MM; Collatos C
    Vet Clin North Am Equine Pract; 1997 Apr; 13(1):43-52. PubMed ID: 9106342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine degenerative myeloencephalopathy in five Quarter Horses: clinical and neuropathological findings.
    Gandini G; Fatzer R; Mariscoli M; Spadari A; Cipone M; Jaggy A
    Equine Vet J; 2004 Jan; 36(1):83-5. PubMed ID: 14756378
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy.
    Ma Y; Peng S; Donnelly CG; Ghosh S; Miller AD; Woolard K; Finno CJ
    J Vet Intern Med; 2024; 38(1):417-423. PubMed ID: 37937700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy.
    Hales EN; Habib H; Favro G; Katzman S; Sakai RR; Marquardt S; Bordbari MH; Ming-Whitfield B; Peterson J; Dahlgren AR; Rivas V; Ramirez CA; Peng S; Donnelly CG; Dizmang BS; Kallenberg A; Grahn R; Miller AD; Woolard K; Moeller B; Puschner B; Finno CJ
    J Vet Intern Med; 2021 Sep; 35(5):2473-2485. PubMed ID: 34331715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the development of equine degenerative myeloencephalopathy.
    Dill SG; Correa MT; Erb HN; deLahunta A; Kallfelz FA; Waldron C
    Am J Vet Res; 1990 Aug; 51(8):1300-5. PubMed ID: 2386332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelopathy and vitamin E deficiency in six Mongolian wild horses.
    Liu SK; Dolensek EP; Adams CR; Tappe JP
    J Am Vet Med Assoc; 1983 Dec; 183(11):1266-8. PubMed ID: 6643241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association Study and Subsequent Exclusion of
    Hales EN; Esparza C; Peng S; Dahlgren AR; Peterson JM; Miller AD; Finno CJ
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine degenerative myeloencephalopathy.
    Mayhew IG; deLahunta A; Whitlock RH; Geary JC
    J Am Vet Med Assoc; 1977 Jan; 170(2):195-201. PubMed ID: 833044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses.
    Aleman M; Finno CJ; Higgins RJ; Puschner B; Gericota B; Gohil K; LeCouteur RA; Madigan JE
    J Am Vet Med Assoc; 2011 Sep; 239(6):823-33. PubMed ID: 21916766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy.
    Finno CJ; Estell KE; Winfield L; Katzman S; Bordbari MH; Burns EN; Miller AD; Puschner B; Tran CK; Xu L
    J Vet Intern Med; 2018 Sep; 32(5):1740-1747. PubMed ID: 30133798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.